
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1134 | 1023 | 1134 | 1262 | 1580 | 2495 |
Fund Return | 13.37% | 2.35% | 13.37% | 8.06% | 9.58% | 9.57% |
Place in category | 165 | 301 | 165 | 134 | 95 | 78 |
% in Category | 21 | 36 | 21 | 24 | 20 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Acc | 1.78B | 23.21 | 9.19 | 13.65 | ||
Schroder Global Equity Fund I Inc | 1.78B | 5.20 | 13.20 | 14.01 | ||
QEP Global Core Equity Fund X Acc | 1.45B | 0.52 | 13.97 | 12.58 | ||
QEP Global Core Equity Fund A Acc | 1.45B | 0.47 | 13.63 | 12.23 | ||
QEP Global Core Equity Fund A Inc | 1.45B | 0.51 | 13.66 | 12.23 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Stock Fund GBP Accumulating | 6.16B | 5.77 | 10.32 | 10.29 | ||
Global Stock Fund GBP Distributing | 6.16B | 5.77 | 10.33 | 10.29 | ||
Specialist Value UK Equity I Acc | 943.96M | 7.52 | 6.00 | 5.77 | ||
Specialist Value UK Equity X Acc | 943.96M | 8.20 | 6.71 | 6.55 | ||
Global Income Fund A GBP Inc | 682.84M | 5.39 | 5.30 | 8.46 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 0.96 | 94.73 | -0.53% | |
Taiwan Semicon | TW0002330008 | 0.90 | 998.00 | -0.70% | |
AbbVie | US00287Y1091 | 0.83 | 213.59 | -1.42% | |
AstraZeneca | GB0009895292 | 0.79 | 11,480.0 | -3.06% | |
UnitedHealth | US91324P1021 | 0.78 | 486.04 | +1.21% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review